THE DATA ORGANISATION

New combined therapy helps extend lives of men with prostate cancer

Practice-changing research shows that a combination of androgen deprivation therapy — a commonly used hormone injection — plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients’ prostate cancer at bay for five years. https://www.sciencedaily.com/releases/2022/05/220526125753.htm